JP Morgan Chase
PROF

JP Morgan Chase’s Profound Medical PROF Stock Holding History

JP Morgan Chase’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,503
Closed -$12.8K – 7786
2023
Q4 		$12.8K Buy
+1,503
New +$14.3K ﹤0.01% 6350
2021
Q4 		– Sell
-202
Closed -$3K – 6894
2021
Q3 		$3K Hold
202
– – ﹤0.01% 6300
2021
Q2 		$3K Hold
202
– – ﹤0.01% 6182
2021
Q1 		$4K Buy
+202
New +$4.84K ﹤0.01% 5886
2020
Q3 		– Sell
-835
Closed -$14K – 5702
2020
Q2 		$14K Sell
835
-900
-52% -$11.4K ﹤0.01% 5089
2020
Q1 		$17K Buy
1,735
+100
+6% +$1.3K ﹤0.01% 4982
2019
Q4 		$16K Buy
+1,635
New +$15.1K ﹤0.01% 5339

Other funds holding PROF

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase's PROF Position: Q1 2024 in Review

JP Morgan Chase sold out of Profound Medical (PROF) in Q1 2024, closing a stake of 1,503 shares — an estimated $12.8K sold.

JP Morgan Chase first reported a position in PROF in Q4 2019 and held it in 7 quarters. The position peaked at $17K in Q1 2020. 43 funds tracked by Wall St. Rank hold PROF as of Q1 2024.

  • JP Morgan Chase reported no remaining Profound Medical position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 1,503 Profound Medical shares in Q1 2024, an estimated $12.8K.
  • JP Morgan Chase first reported a position in Profound Medical in Q4 2019 and held it in 7 quarters.
  • JP Morgan Chase's Profound Medical position peaked at $17K in Q1 2020.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.